And obviously the US facing pharma, if you take a Trump call, there is definitely going to be a pressure going forward as such, so that is why we do not like the US focused pharma companies much and we do not have much exposure there, rather no exposure there as such. We are more focused on to domestic pharma. In a diagnostic space, we got the best player, the top player with us.
ITC Hotels shares may rally by 30% led by strong franchise: Jefferies
ITC Hotels: Jefferies initiated coverage on ITC Hotels (ITCH) with a ‘buy’ rating and a target price of Rs 240, citing strong growth potential. It
February 12, 2025